This inventor holds 1 USPTO granted patent. Top assignees: Rutgers, The State University of New Jersey, University of Kentucky Research Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: R Kiplin Guy: Innovator in Malaria Treatment
Introduction
R Kiplin Guy is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of malaria. His innovative work focuses on developing effective methods and compounds to combat drug-resistant strains of malaria.
Latest Patents
R Kiplin Guy holds a patent for "Compositions and methods for treating malaria." This patent discloses methods of treating malaria using tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related pyrrolinones and hydrolysis products. These compounds have shown effectiveness against strains of malaria that are resistant to multiple drugs currently available on the market. The invention also relates to novel compounds and pharmaceutical compositions that include these active ingredients.
Career Highlights
Throughout his career, R Kiplin Guy has worked with reputable institutions such as Rutgers, the State University of New Jersey, and the University of Kentucky Research Foundation. His work has contributed to advancements in medical research and the development of new treatment options for malaria.
Collaborations
R Kiplin Guy has collaborated with notable colleagues, including Spencer Knapp and Robert D Barrows. These partnerships have enhanced his research efforts and contributed to the success of his innovations.
Conclusion
R Kiplin Guy's contributions to malaria treatment through his innovative patent and collaborations with esteemed institutions and colleagues highlight his commitment to advancing medical science. His work continues to play a crucial role in addressing the challenges posed by drug-resistant malaria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile